Edition:
India

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.59USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$2.59
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
23,627
52-wk High
$7.15
52-wk Low
$2.00

Select another date:

Fri, Jan 5 2018

BRIEF-Pernix Therapeutics Will Reduce Workforce By 41 Employees

* PERNIX THERAPEUTICS HOLDINGS INC - WILL REDUCE WORKFORCE BY 41 EMPLOYEES; MAJORITY EXPECTED TO BE WITH CO'S SALES FORCE & COMMERCIAL INFRASTRUCTURE

BRIEF-Pernix Therapeutics files for mixed shelf offering of up to $150 mln

* Pernix Therapeutics Holdings files for mixed shelf offering of up to $150 million - SEC filing‍​ Source text: (http://bit.ly/2jg0Ica) Further company coverage:

BRIEF-Pernix Therapeutics posts Q3 revenue of $40.5 mln

* Pernix Therapeutics reports third quarter 2017 financial results

BRIEF-Pernix Therapeutics announces sale of non-core product

* Pernix Therapeutics Holdings Inc - ‍sale of a non-core product Cedax to SI Pharmaceuticals LLC, for $2 million in gross cash proceeds​ Source text for Eikon: Further company coverage:

BRIEF-Pernix Therapeutics says CFO and president Graham Miao resigns

* Pernix Therapeutics announces planned departure of chief financial officer

BRIEF-Pernix Therapeutics reports qtrly net loss per common share $2.16

* Pernix Therapeutics reports second quarter 2017 financial results and provides business update

BRIEF-Pernix Therapeutics files for resale of up to 10.1 million shares of common stock by selling stockholders - SEC filing‍​

* Pernix Therapeutics files for resale of up to 10.1 million shares of common stock by selling stockholders - SEC filing‍​ Source text: (http://bit.ly/2upc3NQ) Further company coverage:

BRIEF-Pernix Therapeutics Holdings expects Q2 revenues to be between $33 mln and $35 mln

* Pernix Therapeutics pre-announces certain preliminary second quarter 2017 financial results

Select another date: